MG

Mohankumar Gopakumari Didtu

Active Director Partner DIN 11774086
DIN 11774086 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohankumar Gopakumari Didtu

Data last updated:

Mohankumar Gopakumari Didtu is a Partner at Marko Pharma Distributors Llp (since 2026) and Designated Partner at Ammavan Pharma Distributors Llp (since 2026).

DIN 11774086
Primary Designation Partner
First Appointment 17 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner16 Jul 20262026Active
Designated Partner17 Jun 20262026Active

Directorship timeline

Open interactive timeline →
Ammavan Pharma Distributors Llp
Marko Pharma Distributors Llp
Premium access

Shareholding and investment profile for Mohankumar Gopakumari Didtu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohankumar Gopakumari Didtu

Mohankumar Gopakumari Didtu currently holds 2 directorships: Marko Pharma Distributors Llp (Partner, since 16 Jul 2026); Ammavan Pharma Distributors Llp (Designated Partner, since 17 Jun 2026).

Mohankumar Gopakumari Didtu was first appointed on 17 Jun 2026 as Designated Partner at Ammavan Pharma Distributors Llp.

The current boards of Mohankumar Gopakumari Didtu's companies include Dhananjayan Nair Vanajayan (Marko Pharma Distributors Llp), Manoharan Thulaseedharan Nair (Marko Pharma Distributors Llp), Vijayakumar Thankappan (Marko Pharma Distributors Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available